Physician

David Y. Rhee, MD

According to 2025 Medicare claims, David Rhee, MD (NPI: 1417177569) practices ophthalmology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is LONG ISLAND VITREO RETINAL CONSULTANTS PC (NPI: 1437262755; TIN: 112566918) and primary practice location at 11788-5100. Rhee is affiliated with the Northwell Health ACO (ACO ID: A3030) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Rhee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,577 traditional Medicare patients, billed 38,744 HCPCS/CPT codes, and received $4,282,710 in Medicare payments. The top billing code was 92012 (Established patient problem focused exam of visual system). Part D data shows 357 prescription claims across 146 beneficiaries totaling $19,071 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $167,471. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $59,976 and ending at $19,071. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,424	17,927	$3,639,673
2016	1,490	19,961	$3,952,618
2017	1,465	21,343	$4,127,809
2018	1,451	25,237	$4,385,443
2019	1,473	25,520	$4,677,324
2020	1,292	19,238	$3,887,340
2021	1,392	20,005	$3,919,689
2022	1,431	20,454	$3,884,003
2023	1,441	29,984	$4,121,330
2024	1,577	38,744	$4,282,710

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	120	339	$59,976
2016	123	345	$23,380
2017	144	386	$27,288
2018	139	392	$36,203
2019	156	433	$48,281
2020	116	348	$36,069
2021	119	325	$27,816
2022	110	281	$33,504
2023	130	358	$26,754
2024	146	357	$19,071

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92012	Established patient problem focused exam of visual system	811	1,460	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	657	902	$74
92134	Imaging of retina	1,467	3,757	$36
92201	Extended exam of the back part of the eye with retinal drawing	668	909	$21
92202	Extended exam of the back part of the eye with optic nerve drawing	570	768	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	147	6,265	$7,218
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	21	1,493	$3,236
Ofloxacin	Ofloxacin	75	2,441	$1,381
Latanoprost	Latanoprost	29	1,311	$267
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	1,220	$196

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$603	Apellis Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$166,868	Alexion Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Y. Rhee, MD?

Tedicare shows public-source Medicare data for David Y. Rhee, MD (NPI 1417177569), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Y. Rhee, MD have ACO affiliation data?

David Y. Rhee, MD is shown with ACO affiliation data for Northwell Health ACO (MSSP, ACO ID A3030) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to David Y. Rhee, MD?

David Y. Rhee, MD is linked to LONG ISLAND VITREO RETINAL CONSULTANTS PC (billing NPI 1437262755) in the available physician profile data.

Does David Y. Rhee, MD have Open Payments data?

David Y. Rhee, MD has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.